MedPath

Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease (ANOCA-CMD)

Recruiting
Conditions
Index of Microvascular Resistance
Angina Patients With Non-obstructive Coronary Artery Disease
Coronary Microvascular Dysfunction
Registration Number
NCT06503640
Lead Sponsor
China-Japan Friendship Hospital
Brief Summary

The goal of this observational study is to explore the incidence and effect on prognosis of coronary microvascular dysfunction in patients present of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) \>0.80.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • presence of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) >0.80
Exclusion Criteria
  1. acute myocardial infarction
  2. significant valvular heart disease
  3. advanced chronic kidney disease
  4. patients with significant epicardial coronary artery stenosis (>70% in major vessels by diagnostic coronary angiography) needing percutaneous coronary intervention
  5. patients unable to provide written informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MACE in 12 months12 months

major adverse cardiovascular events 12 months, including cardiac death, myocardial infarction, and readmission for angina.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath